Xeris Pharmaceuticals NASDAQ IPO

14/8/2018
IPO

Announced

14/8/2018


Overview:

  • Xeris Pharmaceuticals has raised $98 million with its IPO on NASDAQ.
  • Jefferies, Leerink Partners, RBC Capital Markets and Mizuho Securities acted as underwriters.

Daniel Semerdzhiev - Data analyst

Continue reading...

New to IFLR1000?

Register today for FREE:

  • Understand market dynamics, with data broken by deal type and more
  • Access law firms and lawyers involved in deals
  • Gain unique insight into lawyers recent work
REGISTER NOW

Sign in